Pharmaceutical Press, the Royal Pharmaceutical Society publishing arm, has announced its partnership with Datapharm Ltd.
Under the new partnership, Electronic Medicines Compendium (emc) the latest product to be added to MedicinesComplete, the online medicines information platform
from Pharmaceutical Press.
MedicinesComplete users can easily search emc information, with direct links to the trusted, clinical guidance from the British National Formulary (BNF).
"emc through MedicinesComplete will include printable, ready-to-use patient information leaflets written by manufacturers to use at the point of care, and users
will have access to an unlimited number of searches. In addition, emc will also include the full Summary of Product Characteristics (SmPC) document, which accompanies
all regulator approved medicines in the UK," said the RPS.
Available to all countries outside the UK, emc will be launched early next year on subscription through MedicinesComplete. UK access is available on request.
Healthcare workers, including community pharmacy staff, can book their Covid-19 booster vaccination through the National Booking Service from Wednesday
(September 7) onwards.
NHS England has announced that around seven million people, including those aged 75 and over, people who are immunosuppressed and health and care workers will be
able to book an appointment for their Covid-19 booster vaccinations online or by calling 119.
Eligible staff are encouraged to book an appointment for a booster dose as soon as possible, provided it has been at least three months since their last dose of the
vaccine.
"For other eligible patients (not health and care workers), invitations are being sent out and will be landing on their doormats from Wednesday 7th September
inviting people to book their appointment for the following week without delay. The NHS will contact people when it is their turn to book in for the vaccine -
there will be no need for patients to contact the NHS," said PSNC.
Pharmacists, along with workers from other public sector workplaces, marched on 8 September demanding that the Scottish government take all available action
to mitigate the biggest reduction in living standards workers will have experienced for generations.
Pharmacists Defence' Association (PDA) members participated in the Scottish Trade Unions Congress (STUC) march to let the government know that "Scotland demands
better".
Paul Flynn, PDA national officer, said: "Pharmacists will be unwelcomely familiar with diminished purchasing power and a squeeze on household budgets for patients,
colleagues and pharmacists but what we will see this year and into 2023 will make previous experience pale by comparison."
The march organised by STUC saw thousands of workers, activists and concerned individuals march through the centre of Edinburgh's Historic Old Town in good spirits
while bearing flags and banners, chanting, singing, and calling for change in Scotland.
Dr Rod Hughes sets out how pharmacists can play a pivotal role in steering people with joint pain towards a prevention programme…
Joint health supplements are big business in the UK, with millions of pounds spent over the counter every year. People turn to these supplements for various reasons,
but most are seeking relief from the symptoms of arthritis, a group of painful long-term conditions thought to affect around 10 million people in this country.
Osteoarthritis (OA) is the most common form of arthritis, affecting around eight million people in the UK. The condition is generally age-related, with joint pain
and stiffness developing as the cartilage between the bones gradually wears away.
OA changes and the inflammation involved causes difficulty moving and considerable pain. Rheumatoid arthritis (RA) tends to affect younger people and is caused by
the body's immune system attacking the joints. As a nation we tend to ignore our joints until they cause us problems, resulting in an increasing number of people
taking long-term analgesics to control the pain or needing surgery to repair knees and hips.
Treatment guidelines followed by doctors in the UK recommend that people with arthritis are advised to maintain a healthy weight and keep physically active, while
strengthening their muscles and protecting any damaged joints during daily activities.
The UK Health Security Agency (UKHSA) and the Office for National Statistics (ONS) will jointly launch a new study to gather data on COVID-19 this winter.
The Winter COVID-19 Infection Study (WCIS) will run from November 2023 to March 2024, involving up to 200,000 participants, UKHSA has said on Monday (October 2).
UKHSA previously commissioned the Coronavirus Infection Survey (CIS), conducted by the ONS in collaboration with scientific study leaders from Oxford University,
analysing more than 11.5 million swab tests and 3 million blood tests from April 2020 to March 2023.
Meanwhile, the Winter CIS study involves conducting up to 32,000 lateral flow tests weekly, providing vital insights into COVID-19 prevalence in the broader
community. The sample will be structured to broadly reflect key population characteristics.
Rising chronic illnesses and an aging population are threatening to bankrupt the National Health Service, Labour's Shadow Health Secretary Wes Streeting has
said on October 11.
Streeting announced a substantial £1.1 billion injection to strengthen the NHS with the goal of clearing the backlog and introducing additional clinics on
evenings and weekends.
The frontbencher outlined a reform agenda to ensure NHS is back on its head for the future of healthcare in the UK.
Streeting said that a Labour government will not waste "money we don't have"- instead aims to revolutionise the NHS by shifting its focus from hospitals to
communities.
"Our emphasis is on transitioning from an analogue to a digital framework and prioritising prevention over sickness-oriented healthcare," he noted.
Specialist business property adviser, Christie & Co, on Tuesday (7 November) announced the sale of Macbon Chemist for the first time in 35 years.
The popular community pharmacy, which is located in the heart of the Tollcross area in the east end of Glasgow, dispenses 8,000 National Health System (NHS)
items per month.
Elizabeth McLaughlin owned the pharmacy since 1987, recently decided to retire and sold the pharmacy for an undisclosed sum.
She had been running it along with a team of employed and locum pharmacists.
The pharmacy was bought by Ron Badger who owns and runs another pharmacy in the Drumchapel area of Glasgow.
The National Health Service (NHS) has said that the roll-out of blood-thinning drugs has helped save thousands of lives.
In January 2022, the NHS launched a drive to rapidly expand the use of life-saving direct oral anticoagulants (DOACs) in people who are at increased risk of strokes.
Since then, more than 24 million prescriptions have been given to such patients and around 460,000 more people have started taking the drugs.
This prevented an estimated 17,000 strokes and 4,000 deaths in the last 18 months, as revealed by the new NHS data.
Amanda Pritchard, the NHS chief executive, hailed the "lifesaving NHS rollout" at the King's Fund annual conference.
It is part of a major NHS drive on "prevention" - to catch more killer conditions earlier and save more lives.
Diabetes affects over 537 million people worldwide; by 2045, this is estimated to increase to 783 million. [1] With the growing prevalence of diabetes,
it's even more important to utilise all options to support people with diabetes (PwDs) in managing their daily life with diabetes.
Where do PwDs most often access healthcare support? On average, PwDs visit the pharmacy three-to-eight times more than the general population to obtain medicines
and testing supplies.[2] It is clear that pharmacists play an integral role in empowering the self-management needs of PwDs beyond the traditional role of
supplying medicines. This relationship, however, may be underutilised.
Research suggests there is a lack of broad recognition of pharmacists as a key source of diabetes care, and that resource constraints - particularly following
the COVID-19 pandemic - can interfere with patient education provision and training.[3,4] Furthermore, the circumstances and role of the pharmacy vary, nationally
and internationally. At Roche Diabetes Care we would like to shine a light on the increasing value of community pharmacists as important figures in the well-being
of PwDs.
The National Health Service (NHS) retention programme has benefitted 23 NHS Trusts since it launched in April 2022, with thousands fewer staff leaving
frontline roles.
NHS data showed that 14,000 fewer staff left the service in the 12 months up to August 2023 (108,890) compared to 122,970 the year before.
In a statement released on Thursday, the NHS England said it is expanding the pilot programme across the country to benefit 42 more NHS trusts.
The programme is part of the NHS Long Term Workforce Plan ambition to retain up to 128,000 more staff over the next 15 years in addition to training record
numbers of doctors, nurses and other healthcare professionals.
Under this new initiative, NHS staff are being offered extra flexibility with working hours, clinical 'support squads' have been introduced to help menopausal
women at work, and HR 'stay advocates' are designated to identify ways to keep staff on the brink of leaving.
Laura Wilson, Director of the Royal Pharmaceutical Society (RPS) in Scotland discussed the future of the pharmacy workforce with Michael Matheson,
Cabinet Secretary for Health and Social Care at the SNP conference.
The event, which took place on 17 October in Aberdeen, Scotland featured other health officials including Colin Poolman, Director of the Royal College of
Nursing; Kenryck Lloyd-Jones, Public Affairs and Policy Manager for Scotland, Chartered Society of Physiotherapy; and Chris Marshall, Deputy Editor at Holyrood
Communications.
The Scottish government has recently unveiled its national workforce strategy for health and social care, laying out its plans for achieving recovery, growth,
and transformation.
Wilson highlighted the challenges and opportunities for the pharmacy workforce in Scotland to attract potential pharmacists into the profession and encourage
them to stay within the profession.
"This was a great opportunity to discuss with the Cabinet Secretary the challenges which exist for the pharmacy workforce in Scotland and to highlight some of
the solutions which need to be implemented to ensure a pharmacy workforce in Scotland which is fit for the future," she said.
Prime Minister, Rishi Sunak, has backed pharmacists to play a greater clinical role in the health and well-being of the nation, describing them
as "valuable and trusted" members of the community.
Pharmacists have faced a difficult year with 222 community pharmacies closing in just the first six months.
Boots alone will be closing 300 branches over the next 12 months.
Sunak, however, insisted that his government knows the "hard work of pharmacy teams", and that he wants to "enable them to do more to support the NHS."
Speaking at the annual Sigma Conference in London on Sunday (5 November), the prime minister reiterated that community pharmacy is in line for a much-needed
boost in funding.
"Earlier this year, the government announced plans for further investment of up to £645 million over the next few years to support the Pharmacy First service
for patients," Sunak said in a letter read out at the conference by Lord Dolar Popat.
"This means that community pharmacies will be able to assess patients and provide some options to protect them without a GP appointment."
The UK Health Security Agency (UKHSA) has published the latest national surveillance data on antibiotic prescribing and resistance.
The English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) report showed an increase in antibiotic use in all settings
(apart from dental) in 2022.
According to the report, antibiotic prescribing rose by 8.4 per cent in 2022 compared with 2021, although the number remains below 2019 pre-pandemic levels.
"There are many reasons behind the increase in prescribing, one of which is likely related to decreased immunity and exposure to infections during the
COVID-19 pandemic that may have underpinned the increased transmission in co-circulating infections, namely: influenza (flu), respiratory syncytial virus
(RSV) and group A streptococcus (GAS)," the report stated.
The government has joined hands with Prostate Cancer UK to launch a massive screening trial in the country next year.
Called TRANSFORM, the trial will use innovative screening methods like an MRI scan to detect prostate cancer, which is the most common cancer in men in the UK.
The trail is scheduled for launch in Spring 2024, and recruitment is likely to begin in Autumn 2024.
For the £42 million trial, the government will invest £16 million through the National Institute of Health Research, and £26m will be provided by Prostate Cancer UK.
The Department of Health and Social Care (DHSC) believes that thousands of men's lives could be saved each year if prostate cancer is detected early with
effective screening methods.
Long waiting times for National Health Service (NHS) care are leaving people too sick to work in the UK, which is affecting the country's economy.
One in three people missed work in 2022 due to delays in accessing NHS care, revealed a new survey by Pollsters Savanta.
The market research consultancy surveyed 2,235 people in the UK this month on behalf of the Liberal Democrats.
According to the survey results, 19 per cent of the participants could not go to work as they were waiting for a GP appointment.
While 15 per cent of the respondents had to take a long period off work while they waited for treatment or surgery, 12 per cent missed work as they waited for
emergency dental treatments.
Overall, 36 per cent of those surveyed had missed at least some work because of difficulty getting NHS care.
The NHS Diabetes Prevention Programme, which was introduced in England in 2016, is helping hundreds of thousands of people to lead healthier lives.
People with pre-diabetes are being identified and offered a nine-month behaviour change programme that supports healthier diet and exercise choices to reduce their
risk of developing diabetes.
A study funded by the National Institute for Health and Care Research (NIHR) has found a significant reduction in diabetes risk among patients who had been
referred to the NHS programme.
Three years after their referral, the participants were 20 per cent less likely to have type 2 diabetes than a similar person who was not included in the
programme, the evaluation revealed.
The NHS England has developed and published a new vaccination strategy with an aim to increase national uptake of lifesaving vaccinations, and protect people
against a range of diseases.
Getting vaccinations will become easier than ever before, as the NHS App is being expanded with more additional features.
Improved booking features such as new in-App bookings, invitation alerts and appointment notifications will make "booking a jab as easy as booking a cab," NHS
leaders said.
The NHS App overhaul will also include improved access to medical records, meaning users will be able to see their routine vaccination status over the coming
months and years, making it easier for them to identify any missed vaccinations in their history.
Members of the Pharmacists' Defence Association (PDA) who have benefits in the Boots Pension Scheme have sought support from their union following the recent
communications from the trustees about the removal of the option to retire at 60 without a reduced pension.
The company claimed that retirement between 60-65 years old without a reduced pension was a discretionary benefit, and it has ended with the buy-in deal with Legal
and General.
However, PDA members believe there is insufficient evidence to fully support this claim, and therefore they are questioning whether this option should have been
secured as part of the buy in and not ended with immediate effect.
PDA Union national officer, Paul Moloney said: "Instead, we believe benefit statements issued to members, at the very least are contradictory, and clearly state
that a full pension will be payable from a member's 60th birthday, with no reference to this benefit being discretionary and therefore subject to a regular
review by the trustees. Instead, the benefit statements give the impression that an unreduced pension from 60 is a right with no indication that retirement plans
should not be based on the benefit statements."
Healthcare staff across England are facing increasing winter pressures amid junior doctor's strikes, as thousands of hospital beds are being occupied by
patients with flu, norovirus and Covid-19.
The number of flu patients in hospital has increased by almost two thirds in a week, according to the latest weekly update from the National health Service (NHS).
New NHS figures published on Thursday showed an average of 648 patients were hospitalised with flu per day this week before the industrial action, up from 402
last week. This lasts number is four times the figure reported at the end of last month (160 per in the week ending 26 November).
In a recent meeting with the head of the government's HRT Taskforce, Madelaine McTernan, the National Pharmacy Association (NPA) board members gave a gist on the ongoing medicines supply issues in community pharmacy.
The meeting, which explored possible solutions to end the nationwide shortage of some Hormone Replacement Therapies, took place on Friday (May 20).
Independent contractors Reena Barai and Olivier Picard gave the so-called 'HRT tsar' an overview of the medicines supply issues in community pharmacy and discussed the new Serious Shortage Protocols (SSPs) which the government introduced in response to the on-going HRT disruption.
Earlier this month, the NPA attended an HRT summit organised by the Department of Health and Social Care, alongside other pharmacy bodies, wholesalers and manufacturers.
Health secretary Sajid Javid and pharmacy minister Maria Caulfield said they would be working collaboratively with manufacturers to meet demand and boost supply.